Delegation of Authority, 19003 [07-1871]

Download as PDF Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices 1600 Clifton Road, Mail Stop E–28, Atlanta, GA 30303, telephone: 404/498– 0003, fax: 404/498–0059, E-mail: smalcom@cdc.gov. The deadline for notification of attendance is May 2, 2007. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7188 Filed 4–13–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Michael O. Leavitt, Secretary. [FR Doc. 07–1871 Filed 4–13–07; 8:45 am] Centers for Medicare and Medicaid Services BILLING CODE 4120–03–M cprice-sewell on PROD1PC66 with NOTICES Delegation of Authority Notice is hereby given that I have delegated to the Administrator of the Centers for Medicare and Medicaid Services, the following authority vested in the Secretary of Health and Human Services. Subpoenas for the Health Insurance Portability and Accountability Act of 1996 (HIPAA): Authority under Section 205(d) of the Social Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation or compliance review for failure to comply with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) standards and requirements related at 45 CFR parts 160, 162 and 164 (except to the extent they pertain to the standards for privacy of individually identifiable health information). Section 1176(a)(2) of the Social Security Act, 42 U.S.C. 1320d–5(a)(2), which provides authority for the imposition of civil money penalties (CMPs) for violations, makes section 1128A of the Social Security Act, 42 U.S.C. 1320a–7a, applicable to the imposition of CMPs for violations of HIPAA administrative simplification standards. Section 1128A(j)(1), 42 U.S.C. 1320a–7a(j)(l), makes section 205(d) and (e) of the Social Security Act, 42 U.S.C. 405(d) and (e), applicable to section 1128A as the subsections are VerDate Aug<31>2005 15:24 Apr 13, 2007 Jkt 211001 with respect to Title II of the Social Security Act. Section 205(d) and (e) authorizes the issuance of subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation by the Secretary and the enforcement of such a subpoena in court in event of refusal to comply. This delegation shall be exercised under the Department’s existing delegation of authority on the issuance of regulations and existing policy on the issuance of regulations. In addition, I hereby affirm and ratify any actions taken by the Administrator of the Centers for Medicare and Medicaid Services, or his subordinates which involved the exercise of the authority delegated herein prior to the effective date of this delegation. This delegation is effective immediately. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Vaccines and Related Biological Products Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public. Name of Committee: Vaccines and Related Biological Products Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on May 16, 2007, from 9 a.m. to 4:30 p.m. and on May 17, 2007, from 8 a.m. to 1 p.m. Location: Hilton Hotel, Washington DC North/Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD 20877. Contact Person: Christine Walsh or Denise Royster, Center for Biologics Evaluation and Research (HFM–71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301–827–0314, or FDA Advisory Committee Information Line, 1–800– 741–8138 (301–443–0572 in the PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 19003 Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting. Agenda: On May 16, 2007, in the morning session, the committee will hear presentations and make recommendations on the safety and effectiveness of influenza virus vaccine live (FluMist) in a pediatric population less than 59 months of age, manufactured by MedImmune Vaccines, Inc. In the afternoon, the committee will hear an overview of the function of the Laboratory of Bacterial Polysaccharides and the Laboratory of Enteric & Sexually Transmitted Diseases, Division of Bacterial Parasitic and Allergenic Products, Office of Vaccines Research and Review, CBER and in closed session will discuss the report of the November 29, 2006, laboratory site visit. On May 17, 2007, the committee will hear presentations and make recommendations on the safety and immunogenicity of a live vaccinia virus smallpox vaccine (ACAM2000) manufactured by Acambis, Inc. FDA intends to make background material available to the public no later than 1 business day before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at http://www.fda.gov/ohrms/ dockets/ac/acmenu.htm, click on the year 2007 and scroll down to the appropriate advisory committee link. Procedure: On May 16, 2007, from 9 a.m. to 3:50 p.m. and on May 17, 2007, from 8 a.m. to 1 p.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before May 2, 2007. Oral presentations from the public will be scheduled between approximately 11:45 a.m. to 12:15 p.m. and 3:20 p.m. to 3:50 p.m. on May 16, 2007, and between approximately 11:15 a.m. to 11:45 a.m. on May 17, 2007. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before April 24, 2007. Time allotted for each presentation may be limited. If the number of registrants requesting to E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 72, Number 72 (Monday, April 16, 2007)]
[Notices]
[Page 19003]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1871]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare and Medicaid Services


Delegation of Authority

    Notice is hereby given that I have delegated to the Administrator 
of the Centers for Medicare and Medicaid Services, the following 
authority vested in the Secretary of Health and Human Services.
    Subpoenas for the Health Insurance Portability and Accountability 
Act of 1996 (HIPAA): Authority under Section 205(d) of the Social 
Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue 
subpoenas requiring the attendance and testimony of witnesses and the 
production of any evidence that relates to any matter under 
investigation or compliance review for failure to comply with the 
Health Insurance Portability and Accountability Act of 1996 (HIPAA) 
standards and requirements related at 45 CFR parts 160, 162 and 164 
(except to the extent they pertain to the standards for privacy of 
individually identifiable health information).
    Section 1176(a)(2) of the Social Security Act, 42 U.S.C. 1320d-
5(a)(2), which provides authority for the imposition of civil money 
penalties (CMPs) for violations, makes section 1128A of the Social 
Security Act, 42 U.S.C. 1320a-7a, applicable to the imposition of CMPs 
for violations of HIPAA administrative simplification standards. 
Section 1128A(j)(1), 42 U.S.C. 1320a-7a(j)(l), makes section 205(d) and 
(e) of the Social Security Act, 42 U.S.C. 405(d) and (e), applicable to 
section 1128A as the subsections are with respect to Title II of the 
Social Security Act. Section 205(d) and (e) authorizes the issuance of 
subpoenas requiring the attendance and testimony of witnesses and the 
production of any evidence that relates to any matter under 
investigation by the Secretary and the enforcement of such a subpoena 
in court in event of refusal to comply.
    This delegation shall be exercised under the Department's existing 
delegation of authority on the issuance of regulations and existing 
policy on the issuance of regulations.
    In addition, I hereby affirm and ratify any actions taken by the 
Administrator of the Centers for Medicare and Medicaid Services, or his 
subordinates which involved the exercise of the authority delegated 
herein prior to the effective date of this delegation.
    This delegation is effective immediately.

Michael O. Leavitt,
Secretary.
[FR Doc. 07-1871 Filed 4-13-07; 8:45 am]
BILLING CODE 4120-03-M